Genetic Technologies Ltd. Is a molecular diagnostic company that provides predictive testing and assessment tools to help doctors proactively manage women's health. It operates in geographical segments in the United States and Australia. The company's product, BREVAGenplus, is a clinically proven non-hereditary breast cancer risk assessment test. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.